5-HT2B Receptor-mediated Cardiac Valvulopathy
5-HT2B receptor agonism causes cardiac valvulopathy, a condition characterized by thickening of the heart valves and as a result, regurgitation of blood within the heart. The anti-obesity drug fenfluramine, which was originally prescribed as an anorectic, was withdrawn from the market due to causing...
Main Author: | Nistala, Pallavi |
---|---|
Format: | Others |
Published: |
VCU Scholars Compass
2018
|
Subjects: | |
Online Access: | https://scholarscompass.vcu.edu/etd/5689 https://scholarscompass.vcu.edu/cgi/viewcontent.cgi?article=6777&context=etd |
Similar Items
-
No link to cardiac valvulopathy was seen in cabergoline treated patients
by: K Dharshini, et al.
Published: (2012-10-01) -
Long-term cardiac (valvulopathy) safety of cabergoline in prolactinoma
by: Shruti Khare, et al.
Published: (2017-01-01) -
EXPLORING THE CONCEPT OF HUMAN OCT3 INHIBITORS AS A NOVEL CLASS OF ANTIDEPRESSANTS
by: Iyer, Kavita A
Published: (2016) -
Histopathologic characterization of lesios in rheumatic valvulopathy
by: R. Ricca, et al.
Published: (2010-01-01) -
Design, Synthesis and Biological Evaluation of Novel Compounds with CNS-Activity Targeting Cannabinoid and Biogenic Amine Receptors
by: Sherwood, Alexander M
Published: (2014)